Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on January 16, 2019, 10:26:00 am

Title: Mavyret Cures Hep C in All Those With Compensated Cirrhosis in 8 Weeks
Post by: Hep Editors on January 16, 2019, 10:26:00 am

Eight weeks of treatment with AbbVie’s Mavyret (glecaprevir/pibrentasivr) cured all those with genotypes 1, 2, 4, 5 and 6 of hepatitis C virus (HCV) and compensated cirrhosis in a recent trial. Current guidelines call for 12 weeks of treatment.

Presenting their findings at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco (The Liver Meeting), researchers enrolled 280 people with genotypes 1, 2, 4, 5 and 6 and compensated cirrhosis (the milder form of the advanced liver disease) in the nonrandomized, single-arm, open-label multicenter Phase IIIb EXPEDITION-8 study.

For more....
https://www.hepmag.com/article/mavyret-cures-hep-c-compensated-cirrhosis-8-weeks